Classification of demyelinating diseases at the interface between etiology and pathogenesis

Current Opinion in Neurology

Volumn 14, Issue 3, 2001, Pages 253-258

  Lassmann, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

AUTOIMMUNE DISEASE; BRAIN ISCHEMIA; DEMYELINATING DISEASE; DEMYELINATION; DISEASE CLASSIFICATION; HUMAN; IMMUNE MEDIATED INJURY; INFLAMMATORY DISEASE; INTOXICATION; MYELIN DEFICIENCY; PATHOGENESIS; REVIEW;

ANIMALS; BRAIN; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 0034991967     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200106000-00001     Document Type: Review

References (55)

1. The morbid anatomy of the demyelinating diseases
2. Axonal pathology in multiple sclerosis. A historical note
3. Cerebral white matter is highly vulnerable to ischemia
4. Acute inflammatory demyelination in reperfusion nerve injury
5. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy
6. Reduced cerebral blood flow in white matter in ischemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI
7. Binswanger's encephalopathy: Serial sections and morphometry of the cerebral arteries
8. Nasal NK/T cell lymphoma presenting as transverse myelopathy
9. Review of current evidence for apoptosis after spinal cord injury
10. Tunel-positive staining of surface contusions after fatal head injury in man
11. Temporal profile and cell subtype distribution of activated caspase-3 following experimental brain injury
12. Reactions of oligodendrocytes to spinal cord injury: Cell survival and myelin repair
13. Toxic disorders
14. Contribution of microglia/ macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats
15. Gene expression in brain during cuprizone-induced demyelination and remyelination
16. Transgenic Lewis rats overexpressing the proteolipid protein gene: Myelin degeneration and its effect on T-cell mediated experimental autoimmune encephalomyelitis
17. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease
18. Effects of TNF-alpha on immature and mature oligodendrocytes and their progenitors in vitro
19. Hydrogen peroxide induces rapid digestion of oligodendrocyte chromatin into high molecular weight fragments
20. The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes
21. Matrix metalloproteinases in normal human central nervous system, microglia nodules and multiple sclerosis lesions
22. Neuronal injury associated with HIV-1: Approaches and treatment
23. Expression of a complete and functional complement system by human neuronal cells in vitro
24. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease
25. Nerve growth factor protects oligodendrocytes from tumor necrosis factor alpha induced injury through Akt-mediated signalling mechanisms
26. Activated human T cells, B cells and monocytes produce brain derived neurotrophic factor (BDNF) in vitro and in brain lesions: A neuroprotective role of inflammation?
27. Macrophages in CNS remyelination: Friends or foe?
28. Macrophages: Their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress
29. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
30. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive and remyelinated lesions
31. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation
32. Genetics of rat neuroinflammation
33. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
34. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study
35. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance
36. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain
37. AMPA and kainite receptors each mediate excitotoxicity in oligodendroglial cultures
38. Non-N-methyl-D-aspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury
39. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain
40. Rapid ischemic cell death in immature oligodendrocytes: A fatal glutamate release feedback loop
41. Diminished calcium homeostasis and increased susceptibility to excitotoxicity of JS 3/16 progenitor cells after differentiation to oligodendroglia
42. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter
43. Kainate-induced neuronal injury leads to persistent phosphorylation of cAMP response element-binding protein in glial and endothelial cells in the hippocampus
44. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line
45. Neurotrophin-3 (NT-3) diminishes susceptibility of the oligodendroglial lineage to AMPA glutamate receptor-mediated excitotoxicity
46. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia
47. Autoimmune encephalomyelitis ameliorated by AMPA antagonists
48. Glutamate excitotoxicity in a model of multiple sclerosis
49. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children
50. Myelitis
51. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: Clinical phenotypes and gender as important factors
52. Susceptibility to multiple sclerosis: Interplay between genes and environment
53. Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosis
54. Glutathione S-transferase polymorphism in MS: Their relationship to disability
55. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination